Pfizer Stock: Essential Dividend Champion Returns $9.8B to Shareholders
Pfizer closes 2025 with impressive shareholder returns of $9.8 billion, solidifying its position among elite dividend-paying stocks. The pharmaceutical giant demonstrates financial strength through consistent capital distribution.


